Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study.


OBJECTIVE To evaluate the efficacy and safety of oral nicorandil in coronary heart disease (CHD) patients with stable angina. METHOD Eligible patients were randomized 1:1 to the nicorandil or control group. Current standard antianginal treatment was continued in both groups, while the patients in the nicorandil group received an additional 12-week… (More)
DOI: 10.1016/j.ijcard.2016.08.305


  • Presentations referencing similar topics